- Forums
- ASX - By Stock
- RAC
- Ann: Zantrene Improves Immune Therapy Treatment of Melanoma
Ann: Zantrene Improves Immune Therapy Treatment of Melanoma, page-59
-
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.42 |
Change
-0.005(0.35%) |
Mkt cap ! $242.0M |
Open | High | Low | Value | Volume |
$1.43 | $1.43 | $1.42 | $36.54K | 25.74K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1365 | $1.42 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.43 | 3962 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1365 | 1.415 |
3 | 8171 | 1.410 |
3 | 5611 | 1.405 |
8 | 22377 | 1.400 |
3 | 22205 | 1.360 |
Price($) | Vol. | No. |
---|---|---|
1.430 | 3962 | 2 |
1.435 | 800 | 1 |
1.475 | 17069 | 2 |
1.480 | 3055 | 2 |
1.490 | 38352 | 1 |
Last trade - 10.54am 15/11/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online